Huxley Pharmaceuticals Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Huxley Pharmaceuticals General Information
Description
Developer of biochemical products. The company has rights to proprietary form of 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate used for autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
Contact Information
Corporate Office
- Huxley, IA 50124
- United States
Corporate Office
- Huxley, IA 50124
- United States
Huxley Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Huxley Pharmaceuticals FAQs
-
When was Huxley Pharmaceuticals founded?
Huxley Pharmaceuticals was founded in 2008.
-
Where is Huxley Pharmaceuticals headquartered?
Huxley Pharmaceuticals is headquartered in Huxley, IA.
-
What industry is Huxley Pharmaceuticals in?
Huxley Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Huxley Pharmaceuticals a private or public company?
Huxley Pharmaceuticals is a Private company.
-
What is the current valuation of Huxley Pharmaceuticals?
The current valuation of Huxley Pharmaceuticals is .
-
What is Huxley Pharmaceuticals’s current revenue?
The current revenue for Huxley Pharmaceuticals is .
-
When was Huxley Pharmaceuticals acquired?
Huxley Pharmaceuticals was acquired on 26-Oct-2009.
-
Who acquired Huxley Pharmaceuticals?
Huxley Pharmaceuticals was acquired by BioMarin Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
